Institutional shares held 84.5 Million
1.04M calls
1.33M puts
Total value of holdings $6.08B
$74.8M calls
$95.4M puts
Market Cap $7.7B
107,105,000 Shares Out.
Institutional ownership 78.92%
# of Institutions 426


Latest Institutional Activity in CORT

Top Purchases

Q1 2025
Parallel Advisors, LLC Shares Held: 3.97M ($286M)
Q1 2025
Braun Stacey Associates Inc Shares Held: 367K ($26.4M)
Q1 2025
Edgestream Partners, L.P. Shares Held: 64K ($4.6M)
Q1 2025
Emerald Advisers, LLC Shares Held: 62.2K ($4.47M)
Q1 2025
Emerald Mutual Fund Advisers Trust Shares Held: 37.8K ($2.72M)

Top Sells

Q1 2025
Gamma Investing LLC Shares Held: 3.41K ($245K)
Q1 2025
Boston Trust Walden Corp Shares Held: 585K ($42M)
Q1 2025
Synergy Asset Management, LLC Shares Held: 171K ($12.3M)
Q1 2025
Roman Butler Fullerton & CO Shares Held: 3.35K ($241K)
Q1 2025
Campbell Newman Asset Management Inc Shares Held: 33K ($2.37M)

About CORT

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with advanced ovarian tumors, as well as for the treatment of cortisol excess. The company is also developing selective cortisol modulator to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain and other disorders; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was incorporated in 1998 and is headquartered in Menlo Park, California.


Insider Transactions at CORT

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
1.71M Shares
From 14 Insiders
Exercise of conversion of derivative security 1.54M shares
Grant, award, or other acquisition 16.5K shares
Bona fide gift 5.57K shares
Other acquisition or disposition 147K shares
Sell / Disposition
1.34M Shares
From 18 Insiders
Payment of exercise price or tax liability 497K shares
Open market or private sale 663K shares
Bona fide gift 173K shares
Other acquisition or disposition 8.25K shares

Track Institutional and Insider Activities on CORT

Follow CORCEPT THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CORT shares.

Notify only if

Insider Trading

Get notified when an Corcept Therapeutics Inc insider buys or sells CORT shares.

Notify only if

News

Receive news related to CORCEPT THERAPEUTICS INC

Track Activities on CORT